Conditions: Non Small Cell Lung Cancer
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 62
Healthy volunteers: no

Brief summary:
A phase II study to evaluate the efficacy and safety profile of the combination of Pemetrexed and Carboplatin in elderly patients with advanced non-small cell lung cancer

Detailed description:

Arms:
arm 1: Pemetrexed: 500 milligrams per square meter (mg/m\^2), intravenous (IV), every 21 days x 6 cycles.

Carboplatin: Area Under the Curve (AUC) 5, intravenous (IV), every 21 days x 6 cycles.

Interventions: intervention 1: pemetrexed intervention 2: carboplatin
Intervention descriptions: intervention 1: 500 milligrams per square meter (mg/m\^2), intravenous (IV), every 21 days x 6 cycles intervention 2: Area Under the Curve (AUC) 5, intravenous (IV), every 21 days x 6 cycles

Protocol document: